Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
FAQs about Listen to Gynecologic Oncology:How many episodes does Listen to Gynecologic Oncology have?The podcast currently has 95 episodes available.
March 26, 2020Special Topics: Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology CareBasic Advice when dealing with COVID-19...more33minPlay
March 25, 2020PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal CancersHosted by: Dr. Deborah K. Armstrong and Featuring: Dr. Eskander, Dr. O'Cearbhaill, Dr. Pothuri...more27minPlay
March 25, 2020March 2020 Editor's Choice: PARP Inhibitor Maintenance Therapy after Initial ChemotherapyEditor's Choice Paper: "Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making" and Editorial Paper: "Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations" Hosted by: Dr. Deborah K. Armstrong and Featuring: Dr. Eskander, Dr. Cearbhaill, Dr. Pothuri...more27minPlay
February 26, 2020February 2020 Editor's Choice: Financial hardship among gynecologic cancer patientsEditor's Choice Paper: "Extensive financial hardship among gynecologic cancer patients starting a new line of therapy" and Editorial Paper: "Financial toxicity: An adverse effect worth of a black box warning?" Hosted by: Dr. Beth Karlan, Editor-In-Chief and Featuring: Dr. Karlan, Dr. Liang, Dr. Rauh-Hain...more19minPlay
February 26, 2020February 2020 Editor's Choice: Financial hardship among gynecologic cancer patientsEditor's Choice Paper: Extensive financial hardship among gynecologic cancer patients starting a new line of therapy Editorial Paper: Financial toxicity: An adverse effect worth of a black box warning?Hosted by: Dr. Beth Karlan, Editor-In-Chief Featuring: Dr. Karlan, Dr. Liang, Dr. Rauh-Hain...more19minPlay
January 30, 2020January 2020 Editor’s Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?Editor's Choice Paper: Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature Editorial Paper: Not All Peritoneal Implants Are Created EqualHosted by: Dr. David Cohn, Deputy Editor Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih...more0minPlay
January 30, 2020January 2020 Editor's Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?Editor's Choice Paper: "Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature" and Editorial Paper: "Not All Peritoneal Implants Are Created Equal" Hosted by: Dr. David Cohn, Deputy Editor and Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih...more20minPlay
January 30, 2020January 2020 Editor's Choice - Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?Editor's Choice Paper: "Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature" and Editorial Paper: "Not All Peritoneal Implants Are Created Equal" Hosted by: Dr. David Cohn, Deputy Editor and Featuring: Dr. Cohn, Dr. Fauceglia, Dr. Shih...more20minPlay
January 02, 2020December 2019 Editor's ChoiceEditor's Choice Paper: "A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study" and Editorial Paper: "Sunset, or dawn of a new age for ovarian cancer vaccine therapy?" Hosted by: Dr. Barbara Goff, Deputy Editor and Featuring: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. Goff...more17minPlay
January 02, 2020December 2019 Editor's ChoiceEditor's Choice Paper: "A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study" and Editorial Paper: "Sunset, or dawn of a new age for ovarian cancer vaccine therapy?" Hosted by: Dr. Barbara Goff, Deputy Editor and Featuring: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. Goff...more17minPlay
FAQs about Listen to Gynecologic Oncology:How many episodes does Listen to Gynecologic Oncology have?The podcast currently has 95 episodes available.